-+ 0.00%
-+ 0.00%
-+ 0.00%

On September 14, biopharmaceutical company Telix issued a statement saying that the US Food and Drug Administration has approved its new drug application for Pixclara®, an amino acid positron emission tomography drug for glioma imaging.

Zhitongcaijing·09/14/2026 00:49:04
Listen to the news
On September 14, biopharmaceutical company Telix issued a statement saying that the US Food and Drug Administration has approved its new drug application for Pixclara®, an amino acid positron emission tomography drug for glioma imaging.